| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99233 |
Prolong inpt eval add15 m |
7,236 |
912 |
$36K |
| 99223 |
Prolong inpt eval add15 m |
469 |
348 |
$11K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,129 |
312 |
$8K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,511 |
1,021 |
$4K |
| 99222 |
Initial hospital care, per day, moderate complexity |
129 |
108 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,044 |
775 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
801 |
484 |
$2K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
1,221 |
715 |
$2K |
| 99310 |
Prolong nursin fac eval 15m |
155 |
120 |
$1K |
| 99307 |
|
454 |
311 |
$1K |
| 99306 |
Prolong nursin fac eval 15m |
202 |
168 |
$745.67 |
| 99350 |
Prolong home eval add 15m |
24 |
16 |
$417.56 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
28 |
13 |
$361.81 |
| 99304 |
|
40 |
33 |
$307.70 |
| 99348 |
|
74 |
48 |
$268.94 |
| 99305 |
|
75 |
59 |
$212.75 |
| 99255 |
|
943 |
140 |
$79.55 |
| 99441 |
|
55 |
46 |
$66.12 |
| 99349 |
|
64 |
41 |
$63.93 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
260 |
173 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
69 |
60 |
$0.00 |
| 99336 |
|
593 |
112 |
$0.00 |
| 98981 |
|
20 |
13 |
$0.00 |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
41 |
17 |
$0.00 |
| 98980 |
|
99 |
67 |
$0.00 |
| 96132 |
|
13 |
12 |
$0.00 |
| 99335 |
|
49 |
13 |
$0.00 |